News
As the U.S. defines its AI policy, we must ensure states continue to have the authority to protect kids from new technologies ...
2d
Que.com on MSNAI in FDA Drug Approvals Sparks Controversy Over Fabricated StudiesIn recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...
Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...
Hallucinations are a known problem with generative AI models—and Elsa is no different, according to Jeremy Walsh, the head of ...
WSYM Lansing, MI on MSN5d
Happening Today: church controversy, job fair, Double Up Food Bucks eventHappening Today: church controversy, job fair, Double Up Food Bucks event ...
Software developer Astronomer says former Chief Executive Officer Andy Byron resigned amid controversy following his ...
ProZenith is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA.
Elon Musk’s artificial intelligence (AI) company xAI apologized to users for antisemitic posts authored by its chatbot Grok, pinning the blame on an update after conducting an investigation. … ...
Spectral AI, Inc. (NASDAQ:MDAI) is one of the most popular AI penny stocks to buy according to billionaires. On June 30, Spectral AI (NASDAQ:MDAI) submitted a De Novo 510k application to the FDA ...
Elsa & AI Resource Center As AI becomes a core part of FDA oversight, companies who prepare now will have a distinct market advantage. This isn’t just about compliance, it’s about accelerating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results